osimertinib
astrazeneca
['tagrisso', 'lung', 'herb']
"practice changing": tagrisso after surgery for early non-small cell lung cancer patients with egfr mutation can reduce risk of death by half, says "compelling" study from lead author roy herbst presented at #asco23 
The trusted source for information on cancer built in collaboration with millions of patients and the country's leading academic medical centers.